other glp 1 agonists GLP-1 Receptor as Treatments for Type 2 Diabetes The role of GLP1 receptor

10.2337/dci24-0094 24 da Silva LimaN.CabaleiroA.NovoaE.RiobelloC.KnerrP

It is not yet a clinical treatment target, but it does offer a plausible mechanistic explanation for why some women with PCOS respond to broad metabolic interventions in ways that go beyond their direct mechanism of action

It's silly that they're banned

Consistent with this, increased expression levels of SLC7A5 have been observed in various types of cancer such as breast cancer [45], KRAS-mutated CRC [46], gastric cancer [47], lung cancer [48], pancreatic cancer [49], prostate cancer [50], melanoma [51], ovarian cancer [52] and hepatocellular carcinomas [53], and esophageal cancer [54]